More Mayne Pharma Group Ltd. news
Mayne Pharma Group Ltd.ASX: MYX

FDA approval of Tolsura (SUBA-itraconazole) capsules

Dec 11, 2018 at 10:17 PM EST · Issued by Mayne Pharma Group Ltd.

Filed with ASX · Dec 11, 2018 at 10:17 PM EST

On 6ix: 6ix.com/news/fda-approval-of-tolsura-suba-itraconazole-capsules

Watch Mayne Pharma's latest call↗Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call↗

Mayne Pharma Group Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Mayne Pharma Group Ltd. on 6ix

Earlier from Mayne Pharma

  • 2018 AGM CEOs SpeechNov 28, 2018
  • 2018 AGM Chairmans AddressNov 28, 2018
  • 2018 Full Year Results Investor PresentationAug 23, 2018
  • 2018 Full Year Results Media ReleaseAug 23, 2018
  • Mayne Pharma acquires generic Efudex in the USJul 22, 2018

Later from Mayne Pharma

  • Tolsura (SUBA-itraconazole) capsule now launched in the USJan 29, 2019
  • Half Year AccountsFeb 21, 2019
  • 2019 Half Year Media ReleaseFeb 21, 2019
  • 2019 Half Year Investor PresentationFeb 21, 2019
  • 2019 Full Year Results Media ReleaseAug 22, 2019
All Mayne Pharma news releases↗

Follow Mayne Pharma into a list and get an email when it puts out news.

Follow Mayne Pharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer